WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Events
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Affiliated Programs

12.03.26

Demystifying Biopharma Business Development: Understanding the Process and Thriving as a BD Professional
This full-day workshop will be taught by accomplished business development (BD) professionals with deep experience in both large pharmas and small biotechs, providing perspectives from both sides of the table for biopartnering. If you have ever wondered what BD is, how to work efficiently and effectively with your BD team to advance your company’s strategy and programs, or even how to become a BD professional yourself, this is a good workshop for you (and your colleagues in R&D, regulatory, legal, finance, and even executive positions) to attend. The workshop will include presentations, case studies, and group exercises, and conclude with a panel discussion. 
Affiliated Programs

11.16.26

2026 US-Japan Healthcare Innovation Conference
Wilson Sonsini is pleased to sponsor the 2026 US-Japan Healthcare Innovation Conference.
Affiliated Programs

10.23.26

2026 Biocom Bay Area CEO Summit
Wilson Sonsini is proud to sponsor the Biocom Bay Area CEO Summit, taking place Friday, October 23, at Ram’s Gate Winery in Sonoma.
WSGR Events

10.21.26

Wilson Sonsini Biotech Summit 2026
We invite you to join us for Wilson Sonsini's Third Annual Biotech Summit. This dynamic, high-profile event will convene leaders from across the biotech industry, including prominent investors, CEOs, founders, key decision makers, and researchers.
Affiliated Programs

10.20.26

East Coast NextGen VC Forum 2026
LaunchBio’s NextGen VC Forum is the premier event for venture capital professionals to deepen their knowledge of the life science and biotech sectors while building meaningful connections across the industry. The forum features expert led sessions that offer practical insights into evaluating, supporting, and scaling science-backed startups. Networking is built into the program to help participants expand their reach and grow their networks. Co-created with Wilson Sonsini, the half-day forum includes a networking lunch, three interactive one-hour sessions, and a closing happy hour.
Affiliated Programs

10.18.26

LES 2026 Annual Meeting
Wilson Sonsini is pleased to support the Licensing Executives Society (LES) 2026 Annual Meeting in San Diego on October 18-21, 2026. LES's flagship annual gathering brings together IP and licensing professionals from the industry community. Several of our technology transactions team members are participating in this year's program.
Affiliated Programs

10.17.26

EPPICON 2026 ​- Reimagining Healthy Aging: The Science, Startups and Business of Longevity
Wilson Sonsini is pleased to sponsor EPPIC Global and the EPPICon 2026 annual meeting.
Affiliated Programs

10.09.26

From Lab to Launch: Translating Academic Innovation into Successful University Spinouts
Wilson Sonsini is a proud supporter of San Diego State Division of Research and Innovation. On October 9, 2026, San Diego State University and the National Academy of Inventors will host an informative session for researchers interested in innovation, translation, and spinouts.
Affiliated Programs

10.08.26

Biocom San Diego CEO Summit 2026
Wilson Sonsini is proud to sponsor the Biocom California San Diego CEO Summit, taking place October 8 at the Fairmont Grand Del Mar. Partner Nellie Brutocao will moderate the panel “AI in Life Sciences,” featuring a discussion on how artificial intelligence is transforming biotech—from research and clinical development to infrastructure and enterprise operations—and where it holds the greatest potential to accelerate timelines and reshape how companies operate.
Affiliated Programs

8.05.26

7th In-House Impact: Biopharma Summit
Wilson Sonsini is pleased to sponsor the 7th In-House Impact: Biopharma Summit, a premier gathering designed exclusively for general counsels, chief legal officers, and senior in-house legal leaders across the biopharma industry.
Affiliated Programs

7.22.26

WIB-San Francisco Bay Area & PBSS: Symposium on the Advances in the Development of Therapeutics and Diagnostics for Women’s Health
PBSS is teaming up with Women in Bio (WIB) to host a virtual symposium focused on therapies and diagnostics for women’s health. You’ll hear from other speakers in industry, academia, and non-profit research organizations on their experience raising funding, setting new healthcare standards, and advocating for women’s health. Sara Kenkare-Mitra, formerly at Genentech and Alector, will give a plenary talk followed by panelists from the Gates Foundation, the Buck Institute, and industry experts. At the end of the symposium, there will be a panel for deeper conversations on the successes and current challenges in this space. This is a free industry event; register today.
Speaking Engagements

7.01.26

Wilson Sonsini and DLG to Co-Host Seminar on Building Long-Term Value in Korean Bio-ventures' Global Expansion
Wilson Sonsini is pleased to co-present this seminar alongside Korean law firm DLG, with attorneys Ian Edvalson, Minyoung Shin, and Ariel Jeong speaking on how Korean bio-ventures can build and sustain long-term enterprise value as they expand globally.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Cookie Settings
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.